<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2018-22-2-88-96</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-356</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЛУЧАЙ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRACTICAL NOTES</subject></subj-group></article-categories><title-group><article-title>НАСЛЕДСТВЕННЫЙ ГИПОФОСФАТЕМИЧЕСКИЙ РАХИТ С ГИПЕРКАЛЬЦИУРИЕЙ (КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ)</article-title><trans-title-group xml:lang="en"><trans-title>HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA (CASE REPORT)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Папиж</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Papizh</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Папиж Светлана Валентиновна, кандидат медицинских наук, Научно-исследовательский клинический институт педиатрии им. акад. Ю.Е. Вельтищева РНИМУ им. Н.И. Пирогова, отдел наследственных и приобретенных болезней почек </p><p> </p><p> 125412, Россия,  Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Svetlana V. Papizh, MD, PhD. Research Clinical Institute for Pediatrics n.a. acad. Y.E. Veltishev, Division of Inherited &amp; Acquired Kidney Diseases125412 Moscow, Taldomskaya St., 2</p></bio><email xlink:type="simple">papijsveta@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баширова</surname><given-names>З. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Bashirova</surname><given-names>Z. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баширова Зиля Рамилевна, Научно-исследовательский клинический институт педиатрии им. акад. Ю.Е. Вельтищева РНИМУ им. Н.И. Пирогова, отдел наследственных и приобретенных болезней почек </p><p>125412, Россия,  Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Zilya</p><p>Zilya Bashirova,MD, Research Clinical Institute for Pediatrics n.a. acad. Y.E. Veltishev, Division of Inherited &amp; Acquired Kidney Diseases </p><p>125412 Moscow, Taldomskaya St., 2</p><p>,MD, Research Clinical Institute for Pediatrics n.a. acad. Y.E. Veltishev, Division of Inherited &amp; Acquired Kidney Diseases </p><p>125412 Moscow, Taldomskaya St., 2</p></bio><email xlink:type="simple">bashirova@pedklin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>12</day><month>02</month><year>2020</year></pub-date><volume>22</volume><issue>2</issue><fpage>88</fpage><lpage>96</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Папиж С.В., Баширова З.Р., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Папиж С.В., Баширова З.Р.</copyright-holder><copyright-holder xml:lang="en">Papizh S.V., Bashirova Z.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/356">https://journal.nephrolog.ru/jour/article/view/356</self-uri><abstract><p> Наследственный гипофосфатемический рахит с гиперкальциурией – аутосомно-рецессивное заболевание, патогенетической основой которого является нарушение реабсорбции фосфора в проксимальном отделе нефрона с последующим развитием гипофосфатемии, гиперкальциурии, повышением уровня кальцитриола, снижением уровня паратиреоидного гормона, остеопорозом и костными деформациями. Заболевание относится к группе гипофосфатемических рахитов, обусловлено мутацией в гене SLC34A3, кодирующим натрий-фосфорный ко-транспортер NaPiIIc, ответственный за реабсорбцию фосфора в проксимальном отделе нефрона. В данной статье мы приводим клиническое наблюдение за ребенком с неклассическими проявлениями наследственного гипофосфатемического рахита с гиперкальциурией. Непостоянный характер гипофосфатемии, нормальные значения максимального тубулярного транспорта фосфора, отсутствие повышения сывороточной концентрации кальцитриола, рахитических изменений и нарушения минеральной плотности костной ткани в течение длительного периода наблюдения не позволяли клинически идентифицировать у ребенка один из вариантов гипофосфатемического рахита. Диагноз был подтвержден благодаря результатам полного секвенирования экзома – выявлена ранее неописанная компаунд-гетерозиготная мутация c.1382G&gt;A (p.Trp461Ter) в 13-м экзоне и с.1094-3C&gt;T в 10-м интроне гена SLC34A3. Верификация диагноза позволила пересмотреть подходы к терапии: при наследственном гипофосфатемическом рахите рекомендуется использование только препаратов фосфора, а назначение препаратов витамина D противопоказано в связи с его повышенной эндогенной продукцией.</p></abstract><trans-abstract xml:lang="en"><p>Hereditary hypophosphatemic rickets with hypercalciuria  is a very rare autosomal recessive disease, pathogenic base of which is phosphorus reabsorption disorder in proximal nephron with following development of hypophsphatemia, hypercalciuria calcitriol level increase, decrease of parathyroid hormone, osteopenia and bony deformity. This disease refers to hypophosphatemic rickets, due to mutations in the SLC34A3 gene that encodes the sodium-phosphate cotransporter NaPi-IIc, which is responsible for phosphorus reabsorption in the proximal nephron. In this article, we present a clinical observation for a child with atypical manifestations of hereditary hypophosphatemic rickets with hypercalciuria. The clinical examination showed non constant hypophosphatemia, normal values of  maximum tubular phosphate transport, absence of calcitriol serum concentrations increase, rachitic changes and bone mineral disorders during a long period of observation. It didn’t allow clinically to identify one of the variants of hypophosphatemic rickets in a child. The diagnosis was confirmed by the results of complete exome sequencing which revealed previously undescribed compound heterozygous mutation c.1382G&gt; A (p.Trp461Ter) in exon 13 and p.1094-3C&gt; T in  intron 10 of the SLC34A3 gene. A correct diagnosis allowed us to reconsider the approaches of the treatment: in hereditary rickets recommended only phosphorus supplementation and prescription of vitamin D due to its increased endogenous production. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>гипофосфатемический рахит</kwd><kwd>гиперкальциурия</kwd><kwd>нефрокальциноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypophosphatemic rickets</kwd><kwd>hypercalciuria</kwd><kwd>nephrocalcinosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tieder M, Modai D, Samuel R et al. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 1985; 312: 611–617 doi:10.1056/NEJM198503073121003</mixed-citation><mixed-citation xml:lang="en">Tieder M, Modai D, Samuel R et al. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 1985; 312: 611–617 doi:10.1056/NEJM198503073121003</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Tieder M, Modai D, Shaked U. et al. «Idiopathic» hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 1987; 316: 125–129 doi:10.1056/NEJM198701153160302</mixed-citation><mixed-citation xml:lang="en">Tieder M, Modai D, Shaked U. et al. «Idiopathic» hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 1987; 316: 125–129 doi:10.1056/NEJM198701153160302</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dasgupta D, Wee MJ, Reyes M et al. Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. Am Soc Nephrol 2014; 25(10): 2366–2375 doi: 10.1681/ASN.2013101085</mixed-citation><mixed-citation xml:lang="en">Dasgupta D, Wee MJ, Reyes M et al. Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. Am Soc Nephrol 2014; 25(10): 2366–2375 doi: 10.1681/ASN.2013101085</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Papizh S, Prikhodina L, Vladimirova T et al. Clinical and genetic heterogeneity of early-onset nephrocalcinosis in children. Ped Nephrol 2017; 32: 1758 doi: 10.1007/s00467-017-3753-x</mixed-citation><mixed-citation xml:lang="en">Papizh S, Prikhodina L, Vladimirova T et al. Clinical and genetic heterogeneity of early-onset nephrocalcinosis in children. Ped Nephrol 2017; 32: 1758 doi: 10.1007/s00467-017-3753-x</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bergwitz С, Roslin NM, Tieder M et al. SLC34A3 Mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaP-IIc in maintaining phosphate homeostasis. Am J Hum Genet 2006; 78(2): 179–192 doi: 10.1086/499409</mixed-citation><mixed-citation xml:lang="en">Bergwitz С, Roslin NM, Tieder M et al. SLC34A3 Mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaP-IIc in maintaining phosphate homeostasis. Am J Hum Genet 2006; 78(2): 179–192 doi: 10.1086/499409</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Negri AL. Hereditary hypophosphatemias: New genes in the bone-kidney axis. Nephrology 2007; 12: 317–320 doi: 10.1111/j.1440-1797.2007.00824.x</mixed-citation><mixed-citation xml:lang="en">Negri AL. Hereditary hypophosphatemias: New genes in the bone-kidney axis. Nephrology 2007; 12: 317–320 doi: 10.1111/j.1440-1797.2007.00824.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Phulwani P, Bergwitz C, Jaureguiberry G. et al. Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasisidentification of a novel SLC34A3/NaPi-IIc mutation. Am J Med Genet 2011; 155A: 626–633 doi: 10.1002/ajmg.a.33832</mixed-citation><mixed-citation xml:lang="en">Phulwani P, Bergwitz C, Jaureguiberry G. et al. Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasisidentification of a novel SLC34A3/NaPi-IIc mutation. Am J Med Genet 2011; 155A: 626–633 doi: 10.1002/ajmg.a.33832</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tencza AL, Ichikawa S, Dang A et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/Type IIc sodium-phosphate cotransporter: Presentatión as hypercalciuria and nephrolithiasis. J Clin Endocrinol Metab 2009; 94: 4433–4438 doi: 10.1210/jc.2009-1535</mixed-citation><mixed-citation xml:lang="en">Tencza AL, Ichikawa S, Dang A et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/Type IIc sodium-phosphate cotransporter: Presentatión as hypercalciuria and nephrolithiasis. J Clin Endocrinol Metab 2009; 94: 4433–4438 doi: 10.1210/jc.2009-1535</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Y, Sanderson SR, Reyes M et al. Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred. Bone 2012; 50(5): 1100–1106 doi:10.1016/j.bone.2012.02.015</mixed-citation><mixed-citation xml:lang="en">Yu Y, Sanderson SR, Reyes M et al. Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred. Bone 2012; 50(5): 1100–1106 doi:10.1016/j.bone.2012.02.015</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int 2011; 80(12): 1278–1291 doi: 10.1038/ki.2011.336</mixed-citation><mixed-citation xml:lang="en">Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int 2011; 80(12): 1278–1291 doi: 10.1038/ki.2011.336</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamoto K, Segawa H, Ito M, Kuwahata M. Physiological regulation of renal sodium-dependent phosphate cotransporters. Jpn J Physiol 2004; 54: 93–102 doi: 10.2170/jjphysiol.54.93</mixed-citation><mixed-citation xml:lang="en">Miyamoto K, Segawa H, Ito M, Kuwahata M. Physiological regulation of renal sodium-dependent phosphate cotransporters. Jpn J Physiol 2004; 54: 93–102 doi: 10.2170/jjphysiol.54.93</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Payne RB. Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem 1998; 35: 201–206 doi: 10.1177/000456329803500203 13. Pettifor JM, Thandrayen K. Hypophosphatemic Rickets: Unraveling the Role of FGF23. Calcif Tissue Int 2012; 91: 297–306 doi: 10.1007/s00223-012-9651-0</mixed-citation><mixed-citation xml:lang="en">Payne RB. Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem 1998; 35: 201–206 doi: 10.1177/000456329803500203 13. Pettifor JM, Thandrayen K. Hypophosphatemic Rickets: Unraveling the Role of FGF23. Calcif Tissue Int 2012; 91: 297–306 doi: 10.1007/s00223-012-9651-0</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Areses-Trapote R, López-García JA, Ubetagoyena-Arrieta M. et al. Hereditary hypophosphatemic rickets with hypercalciuria: a case report. Nefrologia 2012; 32(4): 529–534 doi: 10.3265/Nefrologia.pre2012.Apr.11321.</mixed-citation><mixed-citation xml:lang="en">Areses-Trapote R, López-García JA, Ubetagoyena-Arrieta M. et al. Hereditary hypophosphatemic rickets with hypercalciuria: a case report. Nefrologia 2012; 32(4): 529–534 doi: 10.3265/Nefrologia.pre2012.Apr.11321.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Segawa H, Kaneko I, Takahashi A et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 2002; 277: 19665– 9672 doi: 10.1074/jbc.M200943200</mixed-citation><mixed-citation xml:lang="en">Segawa H, Kaneko I, Takahashi A et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 2002; 277: 19665– 9672 doi: 10.1074/jbc.M200943200</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mejia-Gaviria N, Gil-Peña H, Coto E et al. Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: a case report. Orphanet J Rare Dis 2010; 5: 1 doi: 10.1186/1750-1172</mixed-citation><mixed-citation xml:lang="en">Mejia-Gaviria N, Gil-Peña H, Coto E et al. Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: a case report. Orphanet J Rare Dis 2010; 5: 1 doi: 10.1186/1750-1172</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kremke B, Bergwitz C, Ahrens W et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications. Exp Clin Endocrinol Diabetes 2009; 117: 49–56 doi: 10.1055/s-2008-1076716</mixed-citation><mixed-citation xml:lang="en">Kremke B, Bergwitz C, Ahrens W et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications. Exp Clin Endocrinol Diabetes 2009; 117: 49–56 doi: 10.1055/s-2008-1076716</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Carpenter TO, Imel EA, Holm IA et al. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res 2011; 26:1381–1388. doi: 10.1002/jbmr.340</mixed-citation><mixed-citation xml:lang="en">Carpenter TO, Imel EA, Holm IA et al. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res 2011; 26:1381–1388. doi: 10.1002/jbmr.340</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Caballero D, Ponsetto J et al. Response of Npt2a knockout mice to dietary calcium and phosphorus. PLoS One 2017; 12(4): e0176232 doi: 10.1371/journal.pone.0176232</mixed-citation><mixed-citation xml:lang="en">Li Y, Caballero D, Ponsetto J et al. Response of Npt2a knockout mice to dietary calcium and phosphorus. PLoS One 2017; 12(4): e0176232 doi: 10.1371/journal.pone.0176232</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
